Diabetes, heart damage, and angiotensin II. What is the relationship link between them? A minireview
References
- Abderrazak A, Syrovets T, Couchie D, El Hadri K, Friguet B, Simmet T, Rouis M. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol 4, 296–307, 2015.10.1016/j.redox.2015.01.008431593725625584
- Aguilar D, Deswal A, Ramasubbu K, Mann DL, Bozkurt B. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol 105, 373–377, 2010.10.1016/j.amjcard.2009.09.041281321420102951
- Ahmad S, Simmons T, Varagic J, Moniwa N, Chappell MC, Ferrario CM. Chymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue. PLoS One 6, e28501, 2011.10.1371/journal.pone.0028501323674122180785
- Bader M. Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy. Annu Rev Pharmacol Toxicol 50, 439–465, 2010.10.1146/annurev.pharmtox.010909.10561020055710
- Benigni A, Cassis P, Remuzzi G. Angiotensin II revisitado: nuevos roles en inflamacion, inmunologia y envejecimiento. EMBO Mol Med 2, 247–257, 2010.10.1002/emmm.201000080337732520597104
- Brown L, Wall D, Marchant C, Sernia C. Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats. J Endocrinol 154, 355–362, 1997.10.1677/joe.0.15403559291846
- Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615–1625, 2005.10.2337/diabetes.54.6.161515919781
- Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57, 660–671, 2014.10.1007/s00125-014-3171-6396985724477973
- Candido R, Allen TJ, Lassila M, Cao Z, Thallas V, Cooper ME, Jandeleit-Dahm KA. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 109, 1536–1542, 2004.10.1161/01.CIR.0000124061.78478.9415023892
- Carey RM, Padia SH. Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure. Trends Endocrinol Metab 19, 84–87, 2008.10.1016/j.tem.2008.01.00318294862
- Chappell MC. Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Physiol Heart Circ Physiol 310, H137–H152, 2016.10.1152/ajpheart.00618.2015479663126475588
- Costa JC, Costa RS, Silva CG, Coimbra TM. Enalapril reduces the expression of nuclear factor-kappaB and c-Jun N-terminal kinase in the renal cortices of five-sixths-nephrectomized rats. Am J Nephrol 26, 281–286, 2006.10.1159/00009396016772709
- Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108, 1527–1532, 2003.10.1161/01.CIR.0000091257.27563.3214504252
- Crowley SD, Gurley SB, Coffman TM. AT(1) receptors and control of blood pressure: the kidney and more. Trends Cardiovasc Med 17, 30–34, 2007.10.1016/j.tcm.2006.11.00217210476
- Daffu G, del Pozo CH, O’Shea KM, Ananthakrishnan R, Ramasamy R, Schmidt AM. Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. Int J Mol Sci 14,19891–19910, 2013.10.3390/ijms141019891382159224084731
- Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33, 861–868, 2010.10.2337/dc09-1799284504220067962
- Dell’Italia LJ. Translational success stories: angiotensin receptor 1 antagonists in heart failure. Circ Res 109, 437–452, 2011.10.1161/CIRCRESAHA.110.23855021817164
- Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101, 2271–2276, 2000.10.1161/01.CIR.101.19.227110811594
- Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87, E1–E9, 2000.10.1161/01.RES.87.5.e110969042
- ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 31, 1925–1938, 2013.10.1097/HJH.0b013e328364ca4c24107724
- Ferrario CM, Ahmad S, Nagata S, Simington SW, Varagic J, Kon N, Dell’italia LJ. An evolving story of angiotensin-II-forming pathways in rodents and humans. Clin Sci (Lond) 126, 461–469, 2014.10.1042/CS20130400428079524329563
- Ferrario CM, VonCannon J, Jiao Y, Ahmad S, Bader M, Dell’Italia LJ, Groban L, Varagic J. Cardiac angiotensin-(1-12) expression and systemic hypertension in rats expressing the human angiotensinogen gene. Am J Physiol Heart Circ Physiol 310, H995–H1002, 2016.10.1152/ajpheart.00833.2015486733826873967
- Fiordaliso F, Cuccovillo I, Bianchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini R, Masson S. Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci 79, 121–129, 2006.10.1016/j.lfs.2005.12.03616445948
- Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, Scalia R, Eguchi S. Angiotensin II signal transduction: An update on mechanisms of physiology and pathophysiology. Physiol Rev 98, 1627–1738, 2018.10.1152/physrev.00038.2017633510229873596
- Gan W, Ren J, Li T, Lv S, Li C, Liu Z, Yang M. The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation. Biochim Biophys Acta Mol Basis Dis 1864, 1–10, 2018.10.1016/j.bbadis.2017.10.00128986310
- Ganten D, Minnich JL, Granger P, Hayduk K, Brecht HM, Barbeau A, Boucher R, Genest J. Angiotensin-forming enzyme in brain tissue. Science 173, 64–65, 1971.10.1126/science.173.3991.644325865
- Gao J, Marc Y, Iturrioz X, Leroux V, Balavoine F, Llorens-Cortes C. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors. Clin Sci (Lond) 127, 135–148, 2014.10.1042/CS2013039624697296
- Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. J Card Fail 13, 769–773, 2007.10.1016/j.cardfail.2007.06.72317996827
- Giacchetti G, Sechi LA, Rilli S, Carey RM. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab 16, 120–126, 2005.10.1016/j.tem.2005.02.00315808810
- Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25, 6680–6684, 2006.10.1038/sj.onc.120995417072321
- Hayaishi-Okano R, Yamasaki Y, Katakami N, Ohtoshi K, Gorogawa S, Kuroda A, Matsuhisa M, Kosugi K, Nishikawa N, Kajimoto Y, Hori M. Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care 25, 1432–1438, 2002.10.2337/diacare.25.8.143212145246
- Hitomi H, Kiyomoto H, Nishiyama A. Angiotensin II and oxidative stress. Curr Opin Cardiol 22, 311–315, 2007.10.1097/HCO.0b013e3281532b5317556883
- Hobart PM, Fogliano M, O’Connor BA, Schaefer IM, Chirgwin JM. Human renin gene: structure and sequence analysis. Proc Natl Acad Sci U.S.A. 81, 5026–5030, 1984.10.1073/pnas.81.16.50263916306089171
- Horiuchi M, Iwanami J, Mogi M. Regulation of angiotensin II receptors beyond the classical pathway. Clin Sci (Lond) 123, 193–203, 2012.10.1042/CS2011067722548405
- Hrenak J, Paulis L, Simko F. Angiotensin A/Alamandine/MrgD Axis: Another clue to understanding cardiovascular pathophysiology. Int J Mol Sci, 17, 1098, 2016.
- Kang TB, Yang SH, Toth B, Kovalenko A, Wallach D. Activation of the NLRP3 inflammasome by proteins that signal for necroptosis. Methods Enzymol 545, 67–81, 2014.10.1016/B978-0-12-801430-1.00003-225065886
- Kranzhofer R, Browatzki M, Schmidt J, Kubler W. Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes. Biochem Biophys Res Commun 257, 826–828, 1999.10.1006/bbrc.1999.054310208867
- Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 225, 631–637, 2010.10.1002/jcp.22322309850320635395
- Krop M, Danser AH. Circulating versus tissue renin-angiotensin system: on the origin of (pro)renin. Curr Hypertens Rep 10, 112–118, 2008.10.1007/s11906-008-0022-118474177
- Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: implications in cardiovascular remodeling. Curr Opin Nephrol Hypertens 17,168–173, 2008.10.1097/MNH.0b013e3282f521a818277150
- Kuoppala A, Lindstedt KA, Saarinen J, Kovanen PT, Kokkonen JO. Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma. Am J Physiol Heart Circ Physiol 278, H1069– H1074, 2000.10.1152/ajpheart.2000.278.4.H106910749699
- Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ, Szklo M, Ward BJ. Diabetes mellitus and echocardio-graphic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study. Am Heart J 133, 36–43, 1997.10.1016/S0002-8703(97)70245-X
- Lim S, Lee ME, Jeong J, Lee J, Cho S, Seo M, Park S. sRAGE attenuates angiotensin II-induced cardiomyocyte hyper-trophy by inhibiting RAGE-NFκB-NLRP3 activation. Inflamm Res 67, 691–701, 2018.10.1007/s00011-018-1160-929796842
- Livingstone SJ, Looker HC, Hothersall EJ, Wild SH, Lindsay RS, Chalmers J, Cleland S, Leese GP, McKnight J, Morris AD, Pearson DW, Peden NR, Petrie JR, Philip S, Sattar N, Sullivan F, Colhoun HM. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 9, e1001321, 2012.10.1371/journal.pmed.1001321346274523055834
- Lopez-Diez R, Shekhtman A, Ramasamy R, Schmidt AM. Cellular mechanisms and consequences of glycation in atherosclerosis and obesity. Biochim Biophys Acta 1862, 2244–2252, 2016.10.1016/j.bbadis.2016.05.005510117627166197
- Manigrasso MB, Juranek J, Ramasamy R, Schmidt AM. Unlocking the biology of RAGE in diabetic microvascular complications. Trends Endocrinol Metab 25, 15–22, 2014.10.1016/j.tem.2013.08.002387722424011512
- Matsusaka H, Kinugawa S, Ide T, Matsushima S, Shiomi T, Kubota T, Sunagawa K, Tsutsui H. Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarction. J Cardiovasc Pharmacol 48, 95–102, 2006.10.1097/01.fjc.0000245405.41317.6017031262
- Miller RG, Costacou T, Orchard TJ. Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC). Diabetes 68, 409–419, 2019.10.2337/db18-0515634130230409781
- Mosquera J. Papel del receptor para compuestos de glicosilacion avanzada (RAGE) en la inflamacion. Invest Clin 51, 257–268, 2010.
- Munoz N, Pedreanez A, Mosquera J. Angiotensin II induces increased myocardial expression of receptor for advanced glycation end products, monocyte/macrophage infiltration and circulating endothelin-1 in rats with experimental diabetes. Can J Diabetes 44, 651–656, 2020.10.1016/j.jcjd.2020.03.01032654973
- Nagata S, Kato J, Sasaki K, Minamino N, Eto T, Kitamura K. Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Commun 350, 1026–1031, 2006.10.1016/j.bbrc.2006.09.14617045572
- Nehme A, Zibara K. Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection? Hypertens Res 40, 903–909, 2017.10.1038/hr.2017.6528680167
- Nehme A, Zouein FA, Zayeri ZD, Zibara K. An update on the tissue renin angiotensin system and its role in physiology and pathology. J Cardiovasc Dev Dis 6, 14, 2019.10.3390/jcdd6020014
- Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 34, 2436–2443, 2013.10.1093/eurheartj/eht149
- Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86, 747–803, 2006.10.1152/physrev.00036.2005
- Pennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, et al. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. Eur Heart J 40, 621–631, 2019.
- Peters J, Farrenkopf R, Clausmeyer S, Zimmer J, Kantachuvesiri S, Sharp MG, Mullins JJ. Functional significance of prorenin internalization in the rat heart. Circ Res 90, 1135–1141, 2002.10.1161/01.RES.0000019242.51541.99
- Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97, 1916–1923, 1996.10.1172/JCI118623
- Ruiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B, Egido J. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res 86, 1266–1272, 2000.10.1161/01.RES.86.12.1266
- Sanghi S, Kumar R, Smith M, Baker KM, Dostal DE. Activation of protein kinase A by atrial natriuretic peptide in neonatal rat cardiac fibroblasts: role in regulation of the local renin-angiotensin system. Regul Pept 132, 1–8, 2005.10.1016/j.regpep.2005.06.007
- Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100, 8258–8263, 2003.10.1073/pnas.1432869100
- Sequeira Lopez ML, Pentz ES, Nomasa T, Smithies O, Gomez RA. Renin cells are precursors for multiple cell types that switch to the renin phenotype when homeostasis is threatened. Dev Cell 6, 719–728, 2004.10.1016/S1534-5807(04)00134-0
- Singh H, Sen R, Baltimore D, Sharp PA. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319, 154–158, 1986.10.1038/319154a03079885
- Singh VP, Le B, Bhat VB, Baker KM, Kumar R. High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes. Am J Physiol Heart Circ Physiol 293, H939–H948, 2007.10.1152/ajpheart.00391.2007
- Singh VP, Baker KM, Kumar R. Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. Am J Physiol Heart Circ Physiol 294, H1675–H1684, 2008a.10.1152/ajpheart.91493.2007
- Singh VP, Le B, Khode R, Baker KM, Kumar R. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 57, 3297–3306, 2008b.10.2337/db08-0805
- Soubrier F, Wei L, Hubert C, Clauser E, Alhenc-Gelas F, Corvol P. Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications. J Hypertens 11, 599–604, 1993.10.1097/00004872-199306000-00003
- Thorpe SR, Baynes JW. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 25, 275–281, 2003.10.1007/s00726-003-0017-9
- Tigerstedt R, Bergman PQ. Niere und Kreislauf1. Skand Arch Physiol 8, 223–271, 1898.10.1111/j.1748-1716.1898.tb00272.x
- Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem, 275, 33238–33243, 2000.10.1074/jbc.M002615200
- Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, Pannu N, James MT, Hemmelgarn BR; Alberta Kidney Disease Network. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 380, 807–814, 2012.10.1016/S0140-6736(12)60572-8
- van Kats JP, Danser AH, van Meegen JR, Sassen LM, Verdouw PD, Schalekamp MA. Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation 98, 73–81, 1998.10.1161/01.CIR.98.1.73
- van Kesteren CA, Danser AH, Derkx FH, Dekkers DH, Lamers JM, Saxena PR, Schalekamp MA. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension 30, 1389–1396, 1997.10.1161/01.HYP.30.6.13899403558
- Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59, 1428–1459, 2002.10.1007/s00018-002-8520-912440767
- Walters PE, Gaspari TA, Widdop RE. Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension 45, 960–966, 2005.10.1161/01.HYP.0000160325.59323.b815767466
- Watson AM, Li J, Samijono D, Bierhaus A, Thomas MC, Jandeleit-Dahm KA, Cooper ME. Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice. Atherosclerosis 235, 444–448, 2014.10.1016/j.atherosclerosis.2014.05.94524945577
- Weinsaft JW. Effect of ramipril on cardiovascular events in high-risk patients. N Engl J Med 343, 64–66, 2000.10.1056/NEJM20000706343011310896543
- Westermann D, Rutschow S, Jager S, Linderer A, Anker S, Riad A, Unger T, Schultheiss HP, Pauschinger M, Tschope C. Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Diabetes 56, 641–646, 2007.10.2337/db06-116317327431
- Wu C, Lu H, Cassis LA, Daugherty A. Molecular and pathophysiological features of angiotensinogen: A mini review. N Am J Med Sci (Boston) 4, 183–190, 2011.10.7156/v4i4p183329110522389749
- Wu L, Iwai M, Li Z, Li JM, Mogi M, Horiuchi M. Nifedipine inhibited angiotensin II-induced monocyte chemoattractant protein 1 expression: involvement of inhibitor of nuclear factor kappa B kinase and nuclear factor kappa B-inducing kinase. J Hypertens 24, 123–130, 2006.10.1097/01.hjh.0000198031.30095.d116331110
- Xiao L, Pimentel DR, Wang J, Singh K, Colucci WS, Sawyer DB. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 282, C926–C934, 2002.10.1152/ajpcell.00254.200111880281
- Zheng J, Wei CC, Hase N, Shi K, Killingsworth CR, Litovsky SH, Powell PC, Kobayashi T, Ferrario CM, Rab A, Aban I, Collawn JF, DellItalia LJ. Chymase mediates injury and mitochondrial damage in cardiomyocytes during acute ischemia/reperfusion in the dog. PLoS One 9, e94732, 2014.10.1371/journal.pone.0094732398622924733352
Language: English
Page range: 55 - 65
Published on: Feb 18, 2022
Published by: Slovak Academy of Sciences, Mathematical Institute
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Related subjects:
© 2022 Adriana Pedreanez, Jesus Mosquera, Nelson Munoz, Jorge Robalino, Diego Tene, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.